MOVEMENT DISORDERS ADVISOR

Movement Disorders Advisor

Features

Addressing Neuropsychiatric Symptoms in Huntington Disease: Expert Interview

Depression is the most frequently observed psychiatric disorder in HD, with an estimated prevalence of 40% to 50%.
Functional Imaging in Movement Disorders: Diagnostic Advantages

Functional imaging can help neurologists navigate diagnosis and inform treatment and patient outcomes.
Addressing Levodopa-Resistant Parkinson Disease

In later stages of the condition, it is possible that the nerves become incapable of storing dopamine consistently, rendering levodopa practically useless, even if it is administered more regularly.
Managing Complications of Intrathecal Baclofen Therapy

Facilities with strict protocols to prevent problems have been able to report significantly lower complication rates.
Parkinson Disease and the Gut: Treatment Potential Abounds

Current evidence highlights the potential role of cross-talk between the enteric and central nervous systems and the pathogenesis of Parkinson disease.

News

Bipolar Disorder Associated With Increased Risk for Parkinson Disease

By

Brandon May

October 28, 2019

Cerebrospinal Fluid β-amyloid 1-42 Predicts Freezing of Gait in Early Parkinson Disease

By

Neurology Advisor Contributing Writer

December 20, 2018

White Matter Regions Localized to Distinct Pathways in Essential Tremor

By

Neurology Advisor Contributing Writer

December 18, 2018

High Plasma NFL Linked to Poor Cognition in Alzheimer and Parkinson Disease

By

Neurology Advisor Contributing Writer

December 13, 2018

Journal Articles

Oosterwijk CS, Vriend C, Berendse HW, van der Werf YD, van den Heuvel OA. Anxiety in Parkinson’s disease is associated with reduced structural covariance of the striatum.
J Affect Disord. 2018;240:113-120.

Gilbert DL, Murphy TK, Jankovic J, et al. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study
[published online September 7, 2018]. Mov Disord. doi: 10.1002/mds.27457

Rozani V, Gurevich T, Giladi N, et al. Higher serum cholesterol and decreased Parkinson’s disease risk: A statin-free cohort study
[published online August 25, 2018]. Mov Disord. doi: 10.1002/mds.27413

Katz M, Goto Y, Kluger BM, et al. Top ten tips palliative care clinicians should know about Parkinson’s disease and related disorders
[published online September 11, 2018]. J Palliat Med. doi: 10.1089/jpm.2018.0390

Martinez-Martin P, Kulisevsky J, Mir P, Tolosa E, García-Delgado P, Luquin MR. Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire.
NPJ Parkinsons Dis. 2018; 4:20.

Ferrazzoli D, Ortelli P, Zivi I, et al. Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: randomised controlled study
[published online January 10, 2018]. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2017-316437

Patient Education Materials

Huntington’s Disease: Essential Facts for Patients
Essential Tremor: Essential Facts for Patients
Tics and Tourette Syndrome: Essential Facts for Patients
Impulse Control Disorders In Parkinson’s Disease: Essential Facts for Patients
Deep Brain Stimulation for Parkinson’s Disease: Essential Facts for Patients
Dystonia: Essential Facts for Patients

Related Links

Next post in Neurobehavioral Disorders

Children With Autism Found to Have Higher Risk for Obesity